the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title An Open-label, Phase 1b Study of ACP 196 Alone or in Combination With Rituximab in Subjects With Follicular Lymphoma
Official Title An Open-label, Phase 1b Study of ACP 196 Alone or in Combination With Rituximab in Subjects With Follicular Lymphoma
Principal Investigator Smith, Sonali
Brief Summary To characterize the safety profile of ACP 196 alone or in combination with rituximab in subjects with relapsed or refractory Follicular Lymphoma (FL)
Gender Both
Ages 18 Years
Enrollment 36
Accepts Healthy Volunteers No
Lead Sponsor Acerta Pharma BVIndustry
Collaborator
Study Design Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Study Phase Phase 1
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Follicular Lymphoma (FL)
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI